If you can't find the product that you search, please try to download the PDF files in relative catalogue, or contact with
sales@chemieliva.com
   
88128-57-8
2-(3-chloropropyl)-2,5,5-trimethyl-1,3-dioxane
we have introduce more Heterocyclic Series into our product 
Chemieliva succeed in synthesis of BI-6727 755038-65-4
Chemieliva succeed in synthesis of Volasertib 755038-65-4
The current position: Home > ANALYTICAL DEVELOPMENT

A N A L Y T I C A L  D E V E L O P M E N T

Analytical services are critical at every stage of pharmaceutical R&D, from the first synthetic step of even the shortest process, all the way through manufacturing. We provide broad analytical support for preclinical, clinical development, and manufacturing.

To support the development and manufacture of active pharmaceutical ingredients (APIs), we provide analytical method development and validation services, the capability to synthesize and certify analytical reference standards, and an ICH-compliant bulk active stability program.

All customer projects are supported by an on-site analytical team with equipment and expertise in HPLC, GLC, GC-MS, ICP, LC-MS, ion chromatography and NMR, To support drug development, we provide the following analytical services:

Chromatographic Assay Development
The foundation of any analytical development team is the chromatographic development group. Our experienced team of analysts can reliably develop and validate stability indicating and impurity assays for active pharmaceutical ingredients. Our facilities and instrumentation includes HPLCs (including UV/PDA/RI) and multiple GCs. We have particular expertise in API/impurity assays.

Chiral Assay Development
One of our core strengths is developing chiral assays to evaluate enantiomeric purity. Often, the biggest challenge in chiral assay development is to evaluate many different chromatographic stationary phases in order to find the right conditions for the separation. We know that time is imperative; with our state-of-the-art chiral screening platform, we can evaluate up to 18 different chiral stationary phases and multiple solvent conditions in order to identify a preliminary separation, typically within 24 hours.

Impurities Identification
With expertise in isolation and spectroscopy, our scientists can rapidly identify the structure of unknown impurities/degradants in active pharmaceutical ingredients and, intermediates. Our analytical team uses state-of-the-art instrumentation to isolate, analyze and identify impurities. Instrumentation includes several 300 MHz and 500 MHz NMR units, with multinuclear capabilities (1H, 13C, 31P, 19F and 15N), LC/NMR, FTIR, LC/MS/MS, and GC/MS.

Stability Testing
we provide stability testing on pharmaceutically relevant compounds, including APIs and synthetic process impurities. Our services include long-term, intermediate and accelerated testing of APIs and process intermediates.

We offer:
Stability protocol design
Storage of stability samples under ICH conditions
Development and validation of stability-indicating methodology for APIs and drug products
Chromatographic analysis of APIs, preservatives, and determination of impurity profiles
We can develop and validate the appropriate methods or transfer your validated methodology into our laboratory. We welcome client audits to review our Standard Operating Procedures and verify our compliance with current Good Manufacturing Practices.
 

About Chemieliva | Public Relation | Webmap | Contact Us | Sitemap 
重庆装饰导航 东利人造石 IP多多_流量多多 装饰公司导航网|装饰公司|装饰公司排名